Results 131 to 140 of about 48,107 (253)

CT Angiography-Guided Needle Insertion for Interstitial Brachytherapy in Locally Advanced Cervical Cancer

Diagnostics
CT angiography might be a suitable procedure to avoid arterial puncture in combined intracavitary and interstitial brachytherapy for cervical cancer curatively treated with combined chemoradiation and brachytherapy boost.
Alexandra Timea Kirsch-Mangu, Diana Cristina Pop, Alexandru Tipcu, Alexandra Ioana Andries, Gina Iulia Pasca, Zsolt Fekete, Andrei Roman, Alexandru Irimie, Claudia Ordeanu   +8 more
doaj   +1 more source

Results of interstitial HDR brachytherapy for cancer of the lower lip

, 2005
BackgroundHDR brachytherapy has been employed in the treatment of cancers in numerous locations around the body, however, few publications have dealt with primary carcinomas of the head and neck.
Lebioda, Andrzej; Department of Oncology, Collegium Medicum, Nicolaus Copernicus University, Poland; Department of Brachytherapy, Centre of Oncology, Bydgoszcz, Poland, Kabacińska, Renata; Department of Oncology, Collegium Medicum, Nicolaus Copernicus University, Poland; Department of Brachytherapy, Centre of Oncology, Bydgoszcz, Poland, Wronczewska, Anna; Department of Brachytherapy, Centre of Oncology, Bydgoszcz, Poland, Terlikiewicz, Joanna; Department of Oncology, Collegium Medicum, Nicolaus Copernicus University, Poland; Department of Brachytherapy, Centre of Oncology, Bydgoszcz, Poland, Zuchora, Anysja; Department of Brachytherapy, Centre of Oncology, Bydgoszcz, Poland, Makarewicz, Roman; Department of Oncology, Collegium Medicum, Nicolaus Copernicus University, Poland; Department of Brachytherapy, Centre of Oncology, Bydgoszcz, Poland   +5 more
core   +1 more source

A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP‐00)

The Prostate, Volume 86, Issue 8, Page 891-899, June 2026.
ABSTRACT Background Further work is needed to improve treatment outcomes for prostate cancer (PCa), with the repurposing of the α1‐adrenoreceptor antagonists presenting a potential solution. This feasibility clinical trial presents the first prospective data of the use of an α1‐adrenoreceptor antagonist in men undergoing radiotherapy for PCa.
Liam D. King, David Christie, Daniel Cehic, Wendy Dare, Russ Chess‐Williams, Donna Sellers, Catherine McDermott, Alexandra McCarthy, Shailendra Anoopkumar‐Dukie   +8 more
wiley   +1 more source

Brachytherapy in the treatment of cervical cancer: a review

, 2014
Robyn Banerjee,1 Mitchell Kamrava21Department of Radiation Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada; 2Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USAAbstract: Dramatic advances have been ...
Banerjee R, Kamrava M
core  

Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer

, 2017
Purpose: In radical radiotherapy for cervical cancer, high-dose-rate (HDR) brachytherapy is commonly used after external beam radiation therapy (EBRT) to deliver a cumulative EQD2 of 80 to 90 Gy to the primary tumor.
Guan Heng Tay, Yong Wee Foo, Gail Wan Ying Chua, David Boon Harn Tan   +3 more
core   +1 more source

Advances in Erectile Dysfunction Management: What Does Work

Trends in Urology &Men's Health, Volume 17, Issue 3, June 2026.
ABSTRACT Erectile dysfunction (ED) is a prevalent and multifactorial disorder that substantially affects quality of life. Pathophysiology includes vascular, neurogenic, drug‐induced, and psychogenic causes, and frequently coexists with cardiometabolic disease.
Jolie Shen, Daye Park, Jasper Bash, Juan Andino   +3 more
wiley   +1 more source

Targeted microwave ablation of localised prostate cancer (VIOLETTE trial): a prospective multicentre study

BJU International, Volume 137, Issue 6, Page 1032-1039, June 2026.
Objective To assess the oncological outcomes of targeted microwave ablation (TMA) using organ‐based tracking (OBT) Fusion® via KOELIS Trinity® (KOELIS, Meylan, France) in men with intermediate‐risk prostate cancer (PCa): the VIOLETTE trial (ClinicalTrials.gov identifier: NCT04582656) Patients and Method In this prospective phase II, multicentre ...
Nicolas Barry Delongchamps, Alexandre Peltier, Eric Potiron, Franck Bladou, Romain Diamand, Aurel Messas, Jean‐Baptiste Roche, Grégoire Robert, Jean‐Louis Hoepffner, Thierry Piechaud, Julien Anract, Roland van Velthoven   +11 more
wiley   +1 more source

Intensity-modulated vaginal brachytherapy applicator and single- and multi-channel applicators in vaginal cuff brachytherapy

Purpose: To compare the dosimetric performance of vaginal intensity -modulated brachytherapy (IM-BRT) applicator and single- (SC-BRT) and multi -channel brachytherapy (MC-BRT) applicators for vaginal cuff brachytherapy (VC-BRT).
Yıldız, Ferah, Melek Yilmaz, Ferah Yildiz, Husnu Akyol, Fatih Biltekin, Biltekin, Fatih, Akyol, Hüsnü Fadıl, Gültekin, Melis, Melis Gultekin, Yilmaz, Melek Tugce   +9 more
core   +1 more source

β, β‐Dimethylacrylshikonin Triggers Caspase‐Mediated Cell Apoptosis via Heme Oxygenase‐1 Upregulation and ERK/p38 Activation in Prostate Cancer

Journal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT β, β‐Dimethylacrylshikonin (DMAS), a natural naphthoquinone derivative isolated from the root of a biennial herb belonging to the family Boraginaceae, has been demonstrated to exhibit anti‐cancer and anti‐inflammatory features. Yet, the effects of DMAS on restraining the progression of prostate cancer (PC) remain mostly elusive.
Wei‐Chun Weng, Yi‐Hsien Hsieh, Chih‐Hsin Tang, Shian‐Shiang Wang, Chun‐Chuan Su, Shih‐Chi Su, Shun‐Fa Yang   +6 more
wiley   +1 more source